Ascend Wellness Holdings, Inc. (AAWH) Form 10-Q — Nov 12, 2026
Ascend Wellness Holdings filed its Q3 2026 10-Q showing net revenue of $130.0 million, up 4.2% year over year, with gross profit rising to $53.1 million and a swing to a $4.5 million quarterly operating profit from a year-ago loss. The company still posted a quarterly net loss of $27.95 million (-$0.14 per share) as interest expense nearly doubled to $22.0 million, and cash declined to $63.6 million from $85.7 million at year-end 2025. Total debt stands at roughly $338 million, including $300 million of 12.75% term notes due July 2029, and the stockholders' deficit widened to $112.4 million.
Key figures
- Eps
- -$0.14 Q3 basic and diluted; -$0.33 nine months
- Revenue
- $130.019 million (Q3 2026); $373.070 million (nine months 2026)
- Net Income
- -$27.951 million Q3; -$67.250 million nine months
- Total Debt
- $338.339 million (2024 Term Notes $300.0M, sellers' notes $29.156M, Mortgage Note $9.183M)
- Revenue Yoy
- +4.2% Q3 YoY ($124.734M prior year); nine months -1.8% ($380.035M prior year)
- Total Assets
- $879.799 million
- Cash Position
- $63.625 million
- Interest Rate
- 12.75% on 2024 Term Notes; 8.5% on Mortgage Note
- Maturity Date
- July 16, 2029 (2024 Term Notes); September 29, 2030 (Mortgage Note)
- Shares Outstanding
- 203421675
- Gross profit q3
- $53.089 million vs $43.601 million prior year
- Interest expense q3
- $21.977 million vs $12.562 million prior year
- Operating profit q3
- $4.5 million vs -$1.325 million prior year
- Stockholders deficit
- -$112.408 million
- Operating cash flow nine months
- $8.469 million vs $21.737 million prior year
- Finance lease liabilities noncurrent
- $251.678 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.